Annual FCF
-$94.45 M
-$15.68 M-19.91%
31 December 2023
Summary:
Cara Therapeutics annual free cash flow is currently -$94.45 million, with the most recent change of -$15.68 million (-19.91%) on 31 December 2023. During the last 3 years, it has fallen by -$88.62 million (-1518.45%). CARA annual FCF is now -3444.65% below its all-time high of $2.82 million, reached on 31 December 2013.CARA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$13.98 M
-$1.34 M-10.57%
30 September 2024
Summary:
Cara Therapeutics quarterly free cash flow is currently -$13.98 million, with the most recent change of -$1.34 million (-10.57%) on 30 September 2024. Over the past year, it has increased by +$5.98 million (+29.97%). CARA quarterly FCF is now -117.07% below its all-time high of $81.92 million, reached on 31 December 2020.CARA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$77.34 M
+$5.98 M+7.18%
30 September 2024
Summary:
Cara Therapeutics TTM free cash flow is currently -$77.34 million, with the most recent change of +$5.98 million (+7.18%) on 30 September 2024. Over the past year, it has increased by +$21.20 million (+21.51%). CARA TTM FCF is now -435.12% below its all-time high of $23.08 million, reached on 30 September 2021.CARA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.9% | +30.0% | +21.5% |
| 3 y3 years | -1518.5% | +0.9% | -435.1% |
| 5 y5 years | -322.2% | +45.5% | +24.5% |
CARA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1518.5% | at low | -1023.2% | +59.6% | -435.1% | +25.5% |
| 5 y | 5 years | -1518.5% | +13.5% | -117.1% | +63.5% | -435.1% | +37.0% |
| alltime | all time | -3444.7% | +13.5% | -117.1% | +63.5% | -435.1% | +37.0% |
Cara Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.98 M(+10.6%) | -$77.34 M(-7.2%) |
| June 2024 | - | -$12.65 M(-59.6%) | -$83.33 M(-8.6%) |
| Mar 2024 | - | -$31.29 M(+61.1%) | -$91.12 M(-3.5%) |
| Dec 2023 | -$94.45 M(+19.9%) | -$19.42 M(-2.7%) | -$94.45 M(-4.1%) |
| Sept 2023 | - | -$19.97 M(-2.3%) | -$98.54 M(-5.0%) |
| June 2023 | - | -$20.45 M(-40.9%) | -$103.77 M(+18.2%) |
| Mar 2023 | - | -$34.62 M(+47.2%) | -$87.82 M(+11.5%) |
| Dec 2022 | -$78.77 M(+31.0%) | -$23.51 M(-6.7%) | -$78.77 M(+39.4%) |
| Sept 2022 | - | -$25.19 M(+459.4%) | -$56.51 M(+24.4%) |
| June 2022 | - | -$4.50 M(-82.4%) | -$45.43 M(-26.6%) |
| Mar 2022 | - | -$25.57 M(+1953.7%) | -$61.93 M(+3.1%) |
| Dec 2021 | -$60.13 M(+930.3%) | -$1.25 M(-91.2%) | -$60.09 M(-360.4%) |
| Sept 2021 | - | -$14.12 M(-32.8%) | $23.08 M(+49.9%) |
| June 2021 | - | -$21.00 M(-11.4%) | $15.39 M(+76.0%) |
| Mar 2021 | - | -$23.72 M(-129.0%) | $8.75 M(-249.9%) |
| Dec 2020 | -$5.84 M(-94.7%) | $81.92 M(-475.7%) | -$5.84 M(-95.1%) |
| Sept 2020 | - | -$21.80 M(-21.2%) | -$118.92 M(-3.1%) |
| June 2020 | - | -$27.65 M(-27.8%) | -$122.76 M(+2.3%) |
| Mar 2020 | - | -$38.30 M(+22.9%) | -$120.01 M(+9.9%) |
| Dec 2019 | -$109.24 M(+388.3%) | -$31.17 M(+21.6%) | -$109.24 M(+6.6%) |
| Sept 2019 | - | -$25.64 M(+2.9%) | -$102.46 M(+5.3%) |
| June 2019 | - | -$24.90 M(-9.6%) | -$97.34 M(+209.6%) |
| Mar 2019 | - | -$27.54 M(+12.9%) | -$31.44 M(+40.5%) |
| Dec 2018 | -$22.37 M | -$24.39 M(+18.8%) | -$22.37 M(+138.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$20.52 M(-150.0%) | -$9.40 M(-858.8%) |
| June 2018 | - | $41.00 M(-322.0%) | $1.24 M(-102.4%) |
| Mar 2018 | - | -$18.47 M(+61.8%) | -$51.71 M(-5.8%) |
| Dec 2017 | -$54.88 M(+14.1%) | -$11.41 M(+15.5%) | -$54.88 M(-3.3%) |
| Sept 2017 | - | -$9.88 M(-17.3%) | -$56.73 M(-5.8%) |
| June 2017 | - | -$11.95 M(-44.8%) | -$60.24 M(+0.6%) |
| Mar 2017 | - | -$21.64 M(+63.3%) | -$59.90 M(+24.5%) |
| Dec 2016 | -$48.10 M(+123.7%) | -$13.26 M(-1.0%) | -$48.10 M(+23.3%) |
| Sept 2016 | - | -$13.39 M(+15.4%) | -$39.02 M(+16.7%) |
| June 2016 | - | -$11.61 M(+18.0%) | -$33.44 M(+28.2%) |
| Mar 2016 | - | -$9.84 M(+135.7%) | -$26.09 M(+21.4%) |
| Dec 2015 | -$21.50 M(+21.6%) | -$4.17 M(-46.6%) | -$21.50 M(-7.2%) |
| Sept 2015 | - | -$7.82 M(+83.5%) | -$23.16 M(+16.7%) |
| June 2015 | - | -$4.26 M(-18.8%) | -$19.86 M(+0.1%) |
| Mar 2015 | - | -$5.25 M(-10.1%) | -$19.84 M(+12.2%) |
| Dec 2014 | -$17.68 M(-726.2%) | -$5.84 M(+29.5%) | -$17.68 M(+4.6%) |
| Sept 2014 | - | -$4.51 M(+6.2%) | -$16.91 M(+6.7%) |
| June 2014 | - | -$4.25 M(+37.3%) | -$15.85 M(-1121.0%) |
| Mar 2014 | - | -$3.09 M(-39.0%) | $1.55 M(-45.0%) |
| Dec 2013 | $2.82 M(-146.8%) | -$5.07 M(+47.0%) | $2.82 M(-64.2%) |
| Sept 2013 | - | -$3.44 M(-126.2%) | $7.89 M(-30.4%) |
| June 2013 | - | $13.15 M(-823.1%) | $11.33 M(-723.1%) |
| Mar 2013 | - | -$1.82 M | -$1.82 M |
| Dec 2012 | -$6.03 M(-12.1%) | - | - |
| Dec 2011 | -$6.86 M | - | - |
FAQ
- What is Cara Therapeutics annual free cash flow?
- What is the all time high annual FCF for Cara Therapeutics?
- What is Cara Therapeutics annual FCF year-on-year change?
- What is Cara Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Cara Therapeutics?
- What is Cara Therapeutics quarterly FCF year-on-year change?
- What is Cara Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Cara Therapeutics?
- What is Cara Therapeutics TTM FCF year-on-year change?
What is Cara Therapeutics annual free cash flow?
The current annual FCF of CARA is -$94.45 M
What is the all time high annual FCF for Cara Therapeutics?
Cara Therapeutics all-time high annual free cash flow is $2.82 M
What is Cara Therapeutics annual FCF year-on-year change?
Over the past year, CARA annual free cash flow has changed by -$15.68 M (-19.91%)
What is Cara Therapeutics quarterly free cash flow?
The current quarterly FCF of CARA is -$13.98 M
What is the all time high quarterly FCF for Cara Therapeutics?
Cara Therapeutics all-time high quarterly free cash flow is $81.92 M
What is Cara Therapeutics quarterly FCF year-on-year change?
Over the past year, CARA quarterly free cash flow has changed by +$5.98 M (+29.97%)
What is Cara Therapeutics TTM free cash flow?
The current TTM FCF of CARA is -$77.34 M
What is the all time high TTM FCF for Cara Therapeutics?
Cara Therapeutics all-time high TTM free cash flow is $23.08 M
What is Cara Therapeutics TTM FCF year-on-year change?
Over the past year, CARA TTM free cash flow has changed by +$21.20 M (+21.51%)